These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37836432)

  • 1. Pro-Inflammatory Diet Is Correlated with High
    Rocha IMGD; Torrinhas R; Fonseca D; Lyra CO; de Sousa Alves Neri JL; Balmant BD; Callado L; Charlton K; Queiroz N; Waitzberg DL
    Nutrients; 2023 Sep; 15(19):. PubMed ID: 37836432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of calgranulin-C (S100A12) and fecal zonulin as possible non-invasive markers in children with inflammatory bowel disease: a clinical study.
    Cenni S; Casertano M; Trani M; Pacella D; Martinelli M; Staiano A; Miele E; Strisciuglio C
    Eur J Pediatr; 2023 Mar; 182(3):1299-1308. PubMed ID: 36637538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.
    Mooiweer E; Severs M; Schipper ME; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
    J Crohns Colitis; 2015 Jan; 9(1):50-5. PubMed ID: 25518048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New noninvasive biomarkers of intestinal inflammation and increased intestinal permeability in pediatric inflammatory bowel diseases and their correlation with fecal calprotectin: a pilot study.
    Szymanska E; Bierla J; Dadalski M; Wierzbicka A; Konopka E; Cukrowska B; Kierkus J
    Minerva Gastroenterol (Torino); 2023 Dec; 69(4):504-510. PubMed ID: 35436840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease.
    Schwiertz A; Spiegel J; Dillmann U; Grundmann D; Bürmann J; Faßbender K; Schäfer KH; Unger MM
    Parkinsonism Relat Disord; 2018 May; 50():104-107. PubMed ID: 29454662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: Study protocol for a randomized controlled trial.
    Scaioli E; Belluzzi A; Ricciardiello L; Del Rio D; Rotondo E; Mena P; Derlindati E; Danesi F
    Trials; 2019 Jun; 20(1):327. PubMed ID: 31171016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated fecal calprotectin is associated with gut microbial dysbiosis, altered serum markers and clinical outcomes in older individuals.
    Heinzel S; Jureczek J; Kainulainen V; Nieminen AI; Suenkel U; von Thaler AK; Kaleta C; Eschweiler GW; Brockmann K; Aho VTE; Auvinen P; Maetzler W; Berg D; Scheperjans F
    Sci Rep; 2024 Jun; 14(1):13513. PubMed ID: 38866914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin.
    Klingberg E; Magnusson MK; Strid H; Deminger A; Ståhl A; Sundin J; Simrén M; Carlsten H; Öhman L; Forsblad-d'Elia H
    Arthritis Res Ther; 2019 Nov; 21(1):248. PubMed ID: 31771630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
    Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L
    Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis.
    Klingberg E; Strid H; Ståhl A; Deminger A; Carlsten H; Öhman L; Forsblad-d'Elia H
    Arthritis Res Ther; 2017 Feb; 19(1):21. PubMed ID: 28148281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel disease and biomarkers of gut inflammation and permeability in a community with high exposure to perfluoroalkyl substances through drinking water.
    Xu Y; Li Y; Scott K; Lindh CH; Jakobsson K; Fletcher T; Ohlsson B; Andersson EM
    Environ Res; 2020 Feb; 181():108923. PubMed ID: 31759646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary inflammatory potential mediated gut microbiota and metabolite alterations in Crohn's disease: A fire-new perspective.
    Tian Z; Zhuang X; Zhuo S; Zhu Y; Hu S; Zhao M; Tang C; Zhang Z; Li X; Ma R; Zeng Z; Feng R; Chen M
    Clin Nutr; 2022 Jun; 41(6):1260-1271. PubMed ID: 35504169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fecal Calprotectin in Inflammatory Bowel Disease].
    Lee J
    Korean J Gastroenterol; 2016 May; 67(5):233-7. PubMed ID: 27206433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease.
    Bunn SK; Bisset WM; Main MJ; Gray ES; Olson S; Golden BE
    J Pediatr Gastroenterol Nutr; 2001 Jul; 33(1):14-22. PubMed ID: 11479402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fecal calprotectin as a diagnostic marker of inflammatory bowel disease].
    Kostrzewska P; Całkosiński A; Majewski M; Malinowski K
    Pol Merkur Lekarski; 2022 Feb; 50(295):58-61. PubMed ID: 35278302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease.
    Abdelbary MMH; Hatting M; Bott A; Dahlhausen A; Keller D; Trautwein C; Conrads G
    Front Cell Infect Microbiol; 2022; 12():1010853. PubMed ID: 36275026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease.
    Walkiewicz D; Werlin SL; Fish D; Scanlon M; Hanaway P; Kugathasan S
    Inflamm Bowel Dis; 2008 May; 14(5):669-73. PubMed ID: 18240279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation.
    Mooiweer E; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
    Inflamm Bowel Dis; 2014 Feb; 20(2):307-14. PubMed ID: 24374878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease.
    Ashorn S; Honkanen T; Kolho KL; Ashorn M; Välineva T; Wei B; Braun J; Rantala I; Luukkaala T; Iltanen S
    Inflamm Bowel Dis; 2009 Feb; 15(2):199-205. PubMed ID: 18618670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.